Alexey Vinogradov
Direttore/Membro del Consiglio presso XENETIC BIOSCIENCES, INC.
Patrimonio netto: 70 532 $ in data 30/04/2024
Posizioni attive di Alexey Vinogradov
Società | Posizione | Inizio | Fine |
---|---|---|---|
XENETIC BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 19/07/2019 | - |
Independent Dir/Board Member | 19/07/2019 | - | |
PHARMSYNTHEZ | Direttore/Membro del Consiglio | 03/08/2023 | - |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Direttore/Membro del Consiglio | 14/03/2017 | - |
Cantreva LLC | Direttore operativo | 01/09/2017 | - |
Storia della carriera di Alexey Vinogradov
Precedenti posizioni note di Alexey Vinogradov
Società | Posizione | Inizio | Fine |
---|---|---|---|
Togas Middle East LLC | Corporate Officer/Principal | 01/05/2015 | 01/05/2017 |
Togas Group LLC | Corporate Officer/Principal | 01/03/2012 | 01/11/2016 |
ARGOS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 06/02/2014 | 10/06/2016 |
Independent Dir/Board Member | 06/02/2014 | 10/06/2016 | |
Bioprocess Capital Partners Ltd.
Bioprocess Capital Partners Ltd. Investment ManagersFinance Bioprocess Capital Partners Ltd (BCP) is a venture capital firm founded in 2006. The firm is headquartered in Moscow, Russia. | Investitore di Private Equity | 31/12/2010 | 31/12/2010 |
Pharmstandard Ventures
Pharmstandard Ventures Investment ManagersFinance Pharmstandard Ventures (Pharmstd Ventures) is a venture capital subsidiary of Pharmstandard PJSC headquartered in Moscow, Russia. The firm was founded in 2013 by Dr. Andrey Petrov. | Amministratore Delegato | 01/01/2012 | - |
Corporate Officer/Principal | 01/01/2012 | - |
Formazione di Alexey Vinogradov
Moscow State University Lomonosov | Doctorate Degree |
Statistiche
Distribuzione geografica
Russia | 7 |
Stati Uniti | 4 |
Emirati Arabi Uniti | 2 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Settori
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
PHARMSYNTHEZ | Health Technology |
XENETIC BIOSCIENCES, INC. | Health Technology |
Aziende private | 7 |
---|---|
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Bioprocess Capital Partners Ltd.
Bioprocess Capital Partners Ltd. Investment ManagersFinance Bioprocess Capital Partners Ltd (BCP) is a venture capital firm founded in 2006. The firm is headquartered in Moscow, Russia. | Finance |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Health Services |
Pharmstandard Ventures
Pharmstandard Ventures Investment ManagersFinance Pharmstandard Ventures (Pharmstd Ventures) is a venture capital subsidiary of Pharmstandard PJSC headquartered in Moscow, Russia. The firm was founded in 2013 by Dr. Andrey Petrov. | Finance |
Cantreva LLC | |
Togas Middle East LLC | |
Togas Group LLC |
- Borsa valori
- Insiders
- Alexey Vinogradov
- Esperienza